Leadership Expansions in Health Tech Highlight Growth in Digital Care and Operations
Several health technology companies have announced new executive hires, including appointments to leadership roles in marketing, operations, clinical programs, and sales. These moves reflect ongoing growth in digital health, behavioral healthcare, and health IT solutions. The hires span organizations focused on revenue cycle management, AI diagnostics, patient engagement, and clinical decision support.
In November 2026, multiple health technology organizations announced executive leadership expansions across operations, clinical programs, sales, marketing, and digital strategy. EnableComp appointed Matt Capell as COO to enhance revenue cycle management outcomes for hospitals. RevealDx named Dr. Ryan Brevard as Director of Clinical Programs and David Austin as VP of Sales, reinforcing its AI-driven lung nodule diagnostics platform. Rula Health brought on Taylor Hawes as CMO to strengthen patient and partner engagement in behavioral health. Acentra Health named Mihriban Brickner as SVP of Operations, while EBSCO Clinical Decisions elevated Paul Tuten to EVP to expand DynaMed® content integration into clinical workflows. Rezilient Health hired Lisa Ness, an industry veteran with 30 years’ experience, as CRO to grow its self-funded employer and health system partnerships. eClinical Solutions added three new C-suite leaders—Nathan Johnson (CPO), Brian Testa (CPO), and Jessica Allen (CFO)—to support its elluminate® platform, which now serves 19 of the top 50 pharma firms and CROs. Ardent Health named Gaurav Khanna as Chief Digital & Information Officer to advance AI and data strategy in mid-sized urban care settings. Allegheny Health Network appointed Dr. Nipun Merchant as its first Surgeon-in-Chief, effective February 2027. Groups Recover Together brought in Alexandre Thomé as President to scale its value-based SUD care platform, while BeneCard PBF created a new role for Jason P
These leadership expansions could accelerate the integration of digital tools into mainstream healthcare, potentially improving access and efficiency for patients, especially in underserved or high-need populations like those receiving mental health or substance use disorder treatment. The focus on clinical decision support (e.g., EBSCO’s DynaMed®) and AI diagnostics (e.g., RevealDx) may reduce clinician burnout by streamlining workflows, though real-world impact depends on adoption rates and interoperability. Similar to the 2010s surge in EHR implementation, these moves signal a maturation phase where companies are scaling operations rather than just innovating. The involvement of experienced executives—like Lisa Ness and Brad Nations—suggests investors and stakeholders are prioritizing sustainable growth over rapid expansion. However, it remains unclear how these leadership shifts will affect data privacy, algorithmic bias in AI tools, or workforce dynamics in clinical settings. What